Alimera Sciences, Inc. (ALIM)
NASDAQ: ALIM · IEX Real-Time Price · USD
5.52
0.00 (0.00%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Alimera Sciences Revenue

Alimera Sciences had revenue of $90.22M in the twelve months ending March 31, 2024, with 61.75% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $23.01M with 69.87% year-over-year growth. In the year 2023, Alimera Sciences had annual revenue of $80.75M with 49.19% growth.

Revenue (ttm)
$90.22M
Revenue Growth
+61.75%
P/S Ratio
3.21
Revenue / Employee
$585,838
Employees
154
Market Cap
289.18M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202380.75M26.63M49.19%
Dec 31, 202254.13M-4.90M-8.30%
Dec 31, 202159.03M8.21M16.15%
Dec 31, 202050.82M-3.12M-5.79%
Dec 31, 201953.94M7.34M15.76%
Dec 31, 201846.60M10.69M29.76%
Dec 31, 201735.91M1.58M4.60%
Dec 31, 201634.33M11.90M53.01%
Dec 31, 201522.44M14.02M166.39%
Dec 31, 20148.42M6.55M349.95%
Dec 31, 20131.87M--
Dec 31, 20120--
Dec 31, 20110--
Dec 31, 20100--
Dec 31, 20090--
Dec 31, 20080--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Amarin Corporation 277.46M
Zynex 188.68M
Kamada 149.55M
Poseida Therapeutics 82.50M
Enanta Pharmaceuticals 72.88M
Cartesian Therapeutics 25.91M
XOMA Corporation 5.81M
Opthea 385.28K
Revenue Rankings